Top-News
Pharmazeutika Großbritannien

Biodexa Pharmaceuticals plc ADR News

Aktie
WKN:  A3EJMM ISIN:  US59564R7089 US-Symbol:  BDRX
1,12 €
+0,02 €
+1,82%
08:00:14 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
240,00 Tsd.
Marktkapitalisierung *
262,77 Tsd. €
Streubesitz
-
Faktor
0.5
Originalaktie
GB00BNGF1L75
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 27.03.2024

Biodexa Pharmaceuticals plc ADR News

29.11.23 - PR Newswire
Thinking about buying stock in Biomea Fusion, Tuya Inc, Bitfarms, Netflix, or Biodexa Pharmaceuticals?
Thinking about buying stock in Biomea Fusion, Tuya Inc, Bitfarms, Netflix, or Biodexa Pharmaceuticals? PR Newswire
18.09.23 - PR Newswire
Thinking about buying stock in Navios Maritime Holdings, Biodexa Pharmaceuticals, Iovance Biotherapeutics, Neubase Therapeutics, or Iris Energy?
Thinking about buying stock in Navios Maritime Holdings, Biodexa Pharmaceuticals, Iovance Biotherapeutics, Neubase Therapeutics, or Iris Energy? PR Newswire
14.09.22 - ACCESSWIRE
Midatech Pharma PLC Announces ADR Ratio Change
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 14, 2022 / Midatech Pharma (AIM:MTPH)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-...
14.09.22 - ACCESSWIRE
Midatech Pharma PLC Announces Interim Results for the Six Months to 30 June 2022
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 14, 2022 / Midatech Pharma Plc (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the ...
21.06.22 - ACCESSWIRE
Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma
Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma
20.06.22 - ACCESSWIRE
Midatech Pharma PLC Announces Directorate Change
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 20, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-...
10.06.22 - ACCESSWIRE
Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-...
10.06.22 - ACCESSWIRE
Midatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-...
01.06.22 - ACCESSWIRE
Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development
Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma
24.05.22 - ACCESSWIRE
Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-...
26.04.22 - ACCESSWIRE
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP) , a drug delivery technology company focused on improving the bio-​delivery ...
14.04.22 - ACCESSWIRE
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-...
09.03.22 - ACCESSWIRE
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-​delivery and ...
08.03.22 - ACCESSWIRE
Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser
ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-​delivery and ...
17.01.22 - ACCESSWIRE
Midatech Pharma PLC Announces Extension of Janssen collaboration re Q-Sphera
Midatech announces extension of R&D collaboration with Janssen focused on Q-Sphera technology
13.12.21 - ACCESSWIRE
Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective
06.09.21 - ACCESSWIRE
Midatech Pharma PLC Announces Notice of Interim Results
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the ...
12.07.21 - ACCESSWIRE
Midatech Pharma PLC Announces Appointment of Chief Scientific Officer
Midatech Pharma PLC ('Midatech' or the 'Company') Midatech Strengthens Management Team with Appointment of Dr. Dmitry Zamoryakhin as Chief Scientific Officer
17.06.21 - ACCESSWIRE
Midatech Pharma PLC Announces Breakthrough Data Using Q-Sphera Technology
Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technology
09.06.21 - ACCESSWIRE
Midatech Pharma PLC Announces Investor Webinar Scheduled for 17 June 2021
ABINGDON, UK / ACCESSWIRE / June 9, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-​delivery and ...

Newssuche

Videos

newspaper
17.05.24 +9,45%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »